MedDroid
Ask MedDroid
Linagliptin: uses, side effects & brands
Linagliptin is a DPP-4 inhibitor that needs no dose change in kidney disease. It belongs to the Oral diabetes medicine (extra) group. More tablets that control blood sugar in type 2 diabetes by different routes.
Drug type — dosing is set by your doctor
| Measure | Range |
|---|---|
| Drug class | Oral diabetes medicine (extra) |
| Type | Prescription |
| Dose | Individual — ask your doctor or pharmacist |
What it is used for
- Type 2 diabetes, alone with diet and exercise
- With metformin or other diabetes medicines
- Type 2 diabetes in people with kidney disease
Common brand names
- India: Trajenta, Ondero, Lina
- Worldwide: Tradjenta
Common side effects
- Cold-like symptoms
- Cough
- Joint pain
- Low sugar when used with sulfonylureas or insulin
Before taking it — precautions
- Tell your doctor if you have had pancreatitis
- Taking it with sulfonylureas or insulin raises the chance of low sugar
- Tell your doctor if you have had blistering skin conditions
When to see a doctor urgently
- Severe, persistent belly pain spreading to the back, with vomiting (urgent)
- Large blisters or skin erosions
- Swelling of face or throat, or difficulty breathing (urgent)
Not a prescription — no dose shown. The right dose of linagliptin depends on age, weight, kidney/liver function and the condition, so MedDroid does not show a dose here. Always get your dose from a doctor or pharmacist and the leaflet inside the pack. General educational information only.
Frequently asked questions
Why is no dose change needed in kidney disease?
It is cleared mainly through the liver and bile rather than the kidneys.
Does it cause low sugar on its own?
The risk is low when used alone; it rises when combined with sulfonylureas or insulin.
Will it make me gain weight?
It usually has little effect on weight.
Explore more
Sources & further reading
- World Health Organization (WHO)
- MedlinePlus — U.S. National Library of Medicine
- Ministry of Health & Family Welfare, India
- Indian Council of Medical Research (ICMR)
Reviewed by Dr. Sanjay Anbu, MBBS. MedDroid is an AI medical assistant and can make mistakes. It provides general health information, not a diagnosis or medical advice — always consult a qualified clinician. In an emergency, contact your local emergency number immediately.